The relationship between serum chemokine monocyte chemoattractant protein-1 (MCP-1, or CCL2) levels with kidney disease and subclinical cardiovascular disease (CVD) has not been evaluated in the African American (AA) population. The gene discussed is CCL2; the disease is cardiovascular disorder.